Artificial Intelligence (AI) - From promise to practice
FROM ALGORITHMS TO BIOLOGY
Beyond Perfect Patients
AI and Computational Modeling Approaches for Dose Optimisation During Drug Development
Reimagining Pharmacovigilance
EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Datamonitor
Analyst
include the changing patent laws as countries aim to become more TRIPS compliant with India updating its law recently and China in the process of doing so through the WTO Increasing globalization of the generics market with Indian companies becoming involved in Europe and the US and vice versa will also provide an opportunity for generics companies
Articles
Impact Assessment of US Tariff Threat on Indian Healthcare Export
The ongoing tariff fusillades and retorts by the economies like China have precipitated several conundrums and made the trade future nebulous The flat per cent of reciprocal tariff across the sectors include the medical device also The pharmaceutical sector has been kept exempted The current tariff of the Indian drug to the US is zero while the tariffs on US medicines by India is per cent per c...
Research Insights
Ion-pairing HPLC methods to determine EDTA and DTPA in small molecule and biological pharmaceutical formulations
Abstract Ionpairing highperformance liquid chromatographyultraviolet HPLCUV methods were developed to determine two commonly used chelating agents ethylenediaminetetraacetic acid EDTA in Abilify a small molecule drug with aripiprazole as the active pharmaceutical ingredient oral solution and diethylenetriaminepentaacetic acid DTPA in Y
Case Studies
Pediatrician’s Cough And Cold Medication Prescription For Hypothetical Cases: A Cross-Sectional Multi-Centric Case Study
Abstract Cough and cold is the most common cause for hospital visits and so is the use of cough and cold medication CCM A cough and cold medication has been considered to contain a single ingredient SI or multiple ingredients MI like promethazine PRZ chlorpheniramine CPM pseudoephedrine PS phenylephrine PE diphenhydramine DPH dextromethor
Techno Trends
Vertex Pharmaceuticals and CRISPR Therapeutics Unveil Breakthrough CASGEVY™ Gene-Edited Therapy for Sickle Cell Disease
Vertex Pharmaceuticals and CRISPR Therapeutics have collaborated to develop a groundbreaking geneedited therapy known as CASGEVY specifically designed to address sickle cell disease
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
The Role of Genomics in Shaping the Future of Medicine
Smita Agrawal holds a PhD in Chemical Engineering from the University of California, Berkeley. She has over 20 years of research experience in stem cell biology, neuroscience, immunology, genomics, oncology and real-world data. She currently serves as an independent consultant, offering strategic guidance and insights to life sciences companies on genomics, AI, and health care data applications.
Detangling the Diagnostic Odyssey in Neurodevelopmental Disorder by Genomic Consultancy
Emili is a well-known genetic consultant with vast experience in cytogenetics, molecular biology with special emphasis in neurobiology. She is doing human genetics for past 22 years and now is practising genetic counselling as well as continuing her passion for research.
Koutilya basically is an academician in Zoology and has research interest in areas like anti-microbial peptides of amphibians, bio-active components of amphibians and genetic aspects of human reproductive disorder.
The Transformative Impact of AI on Regulatory Affairs
Yu Han, DPhil in Engineering Science from the University of Oxford, brings a rich background with experience at manufacturer, global regulatory affairs CRO, and AI sector. Her expertise spans the regulatory landscapes of Asia, the US, and the EU, providing a comprehensive understanding of global pharmaceutical regulations. Passionate about combining AI technology with healthcare, Yu excels in creating innovative engineering tools to advance medical solutions. Her work leverages engineering methodologies to unravel complexities in the medical listing process, streamlining the global product flow.
<p> </p>
Email: yu.han@eng.ox.ac.uk
The Potential of Cell Free Chromatin Inhibition in Cancer
Divya Mishra is a board certified oncologist with over 17 years’ experience in the pharmaceutical/CRO industry, clinical practice, and academia, in areas of oncology/haematology, family medicine, palliative medicine, and outcomes research. Mishra has worked across multiple geographies and diverse, multicultural settings for organisations such as Pfizer, IQVIA, and SFJ. She is currently working at ICON as a medical director and therapeutic expert for the oncology/haematology disease areas in the APAC region, based in the regional headquarters in Singapore.
press releasesRead more...
Sanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS®
Sanofi is partnering with Emmy Awardwinning actress entrepreneur and mom Keke Palmer to help educate families about the importance of protection against serious RSV lung infection for babies
Approval for Cefiderocol in Australia
Shionogi Co Ltd announced today that it has received marketing authorization from the Therapeutic Goods Administration TGA in Australia for cefiderocol a siderophore cephalosporin developed by Shionogi for the treatment of carbapenemresistant Gramnegative bacterial infections This marketing auth...
Biocon Secures 10-Year Supply Contract for Pertuzumab in Brazil
Biocon Limited an innovationled global biopharmaceuticals company today announced the signing of partnership agreement with Bahiafarma and Bionovis for Pertuzumab in Brazil marking an important milestone
Beyond Annex 1: PDA Aseptic Processing of Biopharmaceuticals Conference 2026 Explores the Future of Sterility Assurance
The Parenteral Drug Association PDA Asia Pacific will host the PDA Aseptic Processing of Biopharmaceuticals Conference on November at the Sheraton Grand Incheon Hotel in Incheon South Korea
ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
AstraZenecas ETCAMAH camizestrant in combination with a cyclindependent kinase CDK inhibitor abemaciclib palbociclib or ribociclib has been approved in the US for the treatment of adult patients
Global Experts to Gather in Osaka for PDA Aseptic Manufacturing and Regulatory Science Symposium 2026
As pharmaceutical manufacturers worldwide continue to navigate the implementation of PICS GMP Annex a landmark international symposium in Japan will bring together regulators industry leaders
EventsRead more...
14 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
14 - 16
Sep 202615 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality Summit
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
LATEST NEWSRead more...
Rezubio Advances RZ-520 into Phase 1 Clinical Trial Following FDA and NMPA Clearances
Rezubio has announced the first cohort dosing in its Phase clinical trial of RZ following Investigational New Drug IND clearances from the US Food and Drug Administration FDA and Chinas National Medical
ZANVASTRO approved by FDA as first disease-modifying treatment for Alexander disease
Ionis Pharmaceuticals has received approval from the US Food and Drug Administration FDA for ZANVASTRO zilganersen to treat Alexander disease AxD in paediatric and adult patients
Global Experts to Gather in Osaka for PDA Aseptic Manufacturing and Regulatory Science Symposium 2026
As pharmaceutical manufacturers worldwide continue to navigate the implementation of PICS GMP Annex a landmark international symposium in Japan will bring together regulators industry leaders
HUTCHMED Enters into Agreement with GSK for Novel KRAS-EGFR Cancer Therapy
HUTCHMED has entered into an exclusive development and licensing agreement with GSK for HMPLA an investigational antibodytargeted therapy conjugate ATTC designed to target KRAS and EGFR in solid tumours
Everest Medicines Receives Approval for CARDAMYST to Treat Acute PSVT
Everest Medicines has received approval from Chinas National Medical Products Administration NMPA for CARDAMYST etripamil nasal spray for the conversion of acute symptomatic episodes
HUTCHMED Announces Approval of ATLED® (Fanregratinib) for FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma
HUTCHMED has received conditional approval from Chinas National Medical Products Administration NMPA for ATLED fanregratinib to treat adults with advanced metastatic or unresectable intrahepatic cholangiocarcinoma ICC with FGFR fusion or rearrangement who have previously received systemic therapy
